FDA Inspection 1012063 — Hiralal Maheshwari, MD
The FDA completed an inspection of Hiralal Maheshwari, MD on May 16, 2017 in Crystal Lake, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 16, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Crystal Lake, IL (United States)
Additional Details
Clinical Investigator (CI)